JW Pharmaceutical (XKRX:001060) Margin of Safety % (DCF Dividends Based): N/A (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:001060 JW Pharmaceutical XKRX:001060
90 GF Score
Price ₩27,250.00
GF Value ₩32,163.65
Valuation Modestly Undervalued
View Full Analysis

What is JW Pharmaceutical Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

JW Pharmaceutical's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

XKRX:001060 vs ZTS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW Pharmaceutical Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Margin of Safety % (DCF Dividends Based) falls into.


XKRX:001060
90GF Score
JW Pharmaceutical XKRX:001060
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JW Pharmaceutical (XKRX:001060) Overvalued in 2026?

Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued. The current stock price of ₩27,250.00 is trading 15.3% below its estimated GF Value™ of ₩32,163.65. GuruFocus considers JW Pharmaceutical to be Modestly Undervalued.

Key valuation signals for XKRX:001060:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: ₩32,163.65 vs. price of ₩27,250.00 (15.3% below fair value)
  • GF Score™: 90/100

No single metric tells the full story. See the XKRX:001060 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JW Pharmaceutical Business Description

Address 2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
90GF Score

Get the complete analysis for XKRX:001060

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩27,250.00
Price
₩32,163.65
GF Value